Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Emerging Infectious Diseases|December 21, 2017
Characterization of a Feline Influenza A(H7N2) VirusMasato Hatta, Gongxun Zhong, Yuwei Gao, et al.Nature|November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsShinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.Plos Pathogens|June 20, 2014
Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infectionYasushi Itoh, Reiko Yoshida, Shintaro Shichinohe, et al.Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.Nature Microbiology|November 27, 2019
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory dropletsMasaki Imai, Makoto Yamashita, Yuko Sakai-Tagawa, et al.Iscience|July 14, 2023
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccinationShinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, et al.Emerging Infectious Diseases|October 5, 2022
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Moe Okuda, et al.Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.Viruses|December 16, 2020
Comparison of Rapid Antigen Tests for COVID-19Seiya Yamayoshi, Yuko Sakai-Tagawa, Michiko Koga, et al.Iscience|June 8, 2023
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescentsMasaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, et al.Pageof 9